market

Pfizer CEO says 'the best days are ahead' as company prepares for a wave of product launches


Pfizer Makes .95 Billion Deal With U.S. For Future COVID-19 Vaccine

Jeenah Moon/Getty Images News

Even after closing a 2022 that he characterizes as “one of the most successful years” in the company’s history, Pfizer (NYSE:PFE) CEO Albert Bourla issued an upbeat assessment of the company’s near-term future on Monday, citing

Readers Also Like:  Sonia Dasgupta on three significant trends in the private equity market in 2023



READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.